This Monster Dividend Growth Stock Is Up 50% So Far This Year

Philip Morris International (PM) has delivered a 50% total return in 2025, outperforming the S&P 500 due to its successful pivot to alternative nicotine products like Iqos and Zyn, which now account for 42% of revenue and 44% of gross profit, and a weaker U.S. dollar boosting international revenue; while its valuation has increased, analysts believe PM can still deliver solid long-term returns through continued growth in alternative nicotine and pricing power in traditional cigarettes, though not at the same rate as recent months.

Analysis

Philip Morris International (PM) has demonstrated significant market outperformance in 2025, delivering a 50% total return while the S&P 500 remained flat. This performance is largely attributed to the company's strategic pivot towards smoke-free products, with brands like Iqos and Zyn now constituting 42% of total revenue and 44% of gross profit, indicative of superior unit economics compared to traditional cigarettes. Specifically, Iqos commands a 77% volume share in its operational markets. Further bolstering PM's financial results is the depreciation of the U.S. dollar, with the Dollar Index falling from approximately 110 to below 100, which positively impacts revenue reported in U.S. dollars from its predominantly international operations. Despite the secular decline in cigarette usage, PM's traditional tobacco segment remains a strong cash generator, with global cigarette usage (excluding China and the U.S.) projected to decline by only 1% in 2025, and the company's combustibles gross profit grew 5.3% year-over-year last quarter due to pricing power. Consequently, PM's forward price-to-earnings ratio has increased to 24 from 14 a year prior, and its dividend yield has moderated to 3% from nearly 6%. While this elevated valuation suggests that the recent pace of share price appreciation may not be sustainable, the company is still positioned for potential double-digit revenue and earnings growth in the coming years, supported by its market-leading alternative nicotine products and enduring strength in traditional tobacco.

Key Decisions for Investors

• Investors should acknowledge that after a 50% appreciation in 2025, Philip Morris International's valuation has increased, with its forward P/E rising to 24, suggesting that a repeat of such rapid gains is unlikely in the immediate future.
• Consider maintaining or initiating positions for long-term growth and income, given the strong performance of smoke-free products like Iqos and Zyn, which now drive 42% of revenue, the tailwind from a weaker U.S. dollar, and a sustainable 3% dividend yield.
• Monitor the continued market penetration and volume growth of Iqos and Zyn, foreign exchange rate fluctuations impacting reported earnings, and the company's ability to exercise pricing power in its combustible segment, as these are key drivers for future returns.
• Expect solid, potentially double-digit, long-term earnings growth and consistent dividend payouts, rather than the 'monster returns' sometimes associated with higher-risk growth stocks, aligning expectations with the company's mature yet evolving business model.